SEC Filing Summary: Landec Corporation (Form 8-K)
Business Context and Reporting Period
This Form 8-K was filed by Landec Corporation on March 29, 2005. The filing reports the consolidated financial results for the third quarter ended February 27, 2005. The document serves as a current report incorporating a press release (Exhibit 99.1) detailing these results.
Key Financial Metrics
The filing text provided does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are referenced as being contained within the attached press release (Exhibit 99.1), which is not included in the source text.
Material Changes
The filing does not explicitly detail material changes versus the prior comparable period within the main text. It directs readers to the attached press release for the announcement of the third-quarter results.
Guidance, Outlook, and Risks
The provided text does not include management commentary, forward-looking guidance, specific risk factors, or contingencies. The filing strictly announces the issuance of the press release regarding the third-quarter results.
Investor Verification Checklist
- Verify the specific revenue and net income figures for the quarter ended February 27, 2005, by reviewing the attached Exhibit 99.1 (Press Release).
- Confirm the year-over-year and quarter-over-quarter performance trends not detailed in this summary.
- Check for any updated financial guidance or operational outlook provided in the full press release.
- Note the discrepancy between the request metadata (Lifecore Biomedical) and the filing registrant (Landec Corporation).